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Electrophysiologic Substrate of Torsade de Pointes   Dispersion of
Repolarization or Early Afterdepolarizations?
BORYS SURAWICZ, MD, FACC
Indianapolis, Indiana
Recent experimental and clinical studies suggest that tor-
sade de pointes may be precipitated by early afterdepolar-
izations in the Purkinje or ventricular muscle fibers . This
hypothesis offers an alternative to the earlier one that
attributes torsade to the underlying dispersion of repolar-
ization . This review lists the clinical conditions associated
with torsade de pointes and examines the experimental
background of the two proposed electrophysiologic sub-
strates of torsade, namely, the dispersion of repolarization
and the early afterdepolarizations .
The strengths and weaknesses of the two hypotheses are
compared in relation to the following characteristics of
Torsade de pointes is a polymorphic ventricular tachycardia
associated with prolonged QT interval or increased U wave
amplitude and amenable to suppression by an increase in
heart rate . When defined in this manner, the arrhythmia has
been recognized as an entity that is distinctly different from
other types of ventricular tachycardia or ventricular fibrilla-
tion (1) . The characteristics and the possible mechanisms of
torsade have been discussed in previous review articles
(2,3) . Interest in this arrhythmia has been rekindled by the
recent experimental and clinical studies designed to test the
hypothesis that torsade de pointes may be caused by a
process known as early afterdepolarizations . This hypothe-
sis offers an alternative to the earlier one that the electro-
physiologic substrate of this arrhythmia is created by an
increased dispersion of repolarization .
It is, therefore, timely and of clinical and research rele-
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torsade de pointes   facilitation by slow heart rate, suppres-
sion by pacing, R on T phenomenon, difficulty of induction
by programmed stimulation, aggravation by hypokalemia,
manifestation of an idiosyncratic reaction to class IA anti-
arrhythmic drugs, spontaneous termination, suppression
by magnesium salts and isoproterenol and induction by
such drugs as sotalol, bepridil and prenylamine . It appears
that most clinical observations can be explained by either
mechanism, but in some cases difficulties are encountered
for the afterdepolarization hypothesis .
(J Am Coll Cardiol 1 8  ;14
 172-84)
vance to examine the experimental background underlying
the two hypotheses and to compare their strengths and
weaknesses . An increased understanding of this relatively
uncommon arrhythmia may contribute to a better under-
standing of some other, more common types of ventricular
arrhythmias .
This discussion will be limited to torsade de pointes as
defined before (1) and will not include the polymorphic
tachycardias that may be morphologically indistinguishable
from torsade but occur I) in the absence of QT lengthening
or increased U wave amplitude, for example, during acute
myocardial ischemia ; 2) in patients with structural heart
disease, for example, chronic ischemic heart disease or
cardiomyopathy . i n which the polymorphic ventricular tachy-
cardias coexist with other types of ventricular tachyarrhyth-
mias ; and 3) in the presence of QT lengthening resulting from
prolongation of the QRS complex without appreciable
lengthening of repolarization, for example, treatment with
class IC antiarrhythmic or certain antidepressant drugs .
Characteristics and Methods of Reproduction
Characteristic pattern . To satisfy the description of tor-
sade de pointes, the axis of the QRS complex must change
direction after a certain number of complexes as if the
complex rotated around the baseline (1) . The phasic varia-
tion of the polarity and amplitude of the QRS complexes may
0735-10 7/8 /$3 .50
JACC Vol
. 14, No
. I
July 1 8    1 7 2-84
!m/O
/!//!s .
not p! plat/ tae/!uu!!!!rs ar a a mrruuuu .arrs irPii"rris ;
Arx
s sssskivopmovrip t rv Us- to  it a∎rrva,isIsm it r,s4 ir .
=3 Yl~C1/llkiili ;ra .4"It
	
k'00 i  .aA'lii .i' >!er
lesos°sasssssssss shame
tit
~sssssis.i it a g li t 1 i i
1
sits/lt//
s11w//rraila!!/t®! r sustraa
.
Sept-2 ,7  4 47 PM
412aiia ~idts + tdbolo 1 0. a  * rA*W* 4i*'!11 a%mid"40rrIdYrd OVA
if
if
ago
News
_ 4F M
646 PM.
Figure 1 . Example of torsade de pointes in a 37 year old woman
with hypokalemia who was treated with digitalis, quinidine and
thioridazine . Note the onset of torsade after the sequence of a long
and a short preceding RR interval (upper tracing) . In the lower
tracing, regular sinus rhythm is restored after treatment with atro-
pine  note the prolonged QT interval .
be apparent only if several synchronous leads are recorded .
The intervals between complexes vary, and the rate of
tachycardia ranges from 150 to 300 beats/min (3) . It has been
suggested that the electrical activity in this condition is less
disorganized than that in ventricular fibrillation . This lesser
degree of disorganization and a greater probability of spon-
taneous termination are attributed to a longer period of
refractoriness, which accounts for fewer and perhaps longer
reentrant circuits .
In addition to its characteristic morphologic features,
torsade de pointes differs from sustained monomorphic
ventricular tachycardia by the difficulty of arrhythmia induc-
tion with programmed electrical stimulation (4 .5) and by the
characteristic pattern of onset . In the majority of cases,
torsade is preceded by a characteristic sequence of a long
RR interval of the dominant cycle, followed by a short
extrasystolic interval (3,6) with premature depolarization
interrupting the T wave (R on T phenomenon) (7) (Fig . I) .
Reproduction of the arrhythmia . Bardy et al . (8) repro-
duced the arrhythmia by using burst pacing in the heart of
dogs treated with toxic quinidine doses and subjected to a
brief period of left anterior descending coronary artery
occlusion . The epicardial maps during induced arrhythmia
showed that each change in the QRS configuration was
associated with a change in the site of epicardial break-
through . It appeared that two or more competing activation
sequences were vying for control of epicardial depolariza-
tion (8) . Not surprising, these investigators were able to
simulate torsade de pointes by pacing simultaneously from
two widely separated ventricular sites at slightly different
cycle length .
In another study of dogs treated with toxic quinidine
doses but without coronary artery ligation . epicardial map-
ping during torsade, induced by extrastimuli, suggested an
alteration of the earliest site of activation or a change of the
epicardial activation sequence, or both, rather than an origin
at two or more separate sites ( ) . In dog hearts injected with
aconitine (10), torsade de pointes was attributed to an
increased focus of automaticity and macroreentry involving
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the His bundle, the atrioventricular (AV) node and the atria .
Several additional mechanisms of torsade de pointes could
be generated in the computer model by simulating nonho-
mogeneous electrophysiologic properties of the conducting
system and the myocardium (11) . Both the experimental
animal models and the computer simulations reproduce the
configuration but do not elucidate the electrophysiologic
substrate and the mechanisms triggering the clinical arrhyth-
mias .
Clinical Conditions Associated With
Torsade de Pointes
Congenital long QT syndrome . The congenital long QT
syndrome represents a unique clinical condition in which the
available evidence strongly suggests that the lengthening of
the QT interval is neurogenic and that the long QT interval is
associated with increased dispersion of repolarization (12) .
Electrocardiograms (ECG) recorded at the onset of torsade
de pointes in this condition show that the arrhythmia is
precipitated by a ventricular premature complex interrupting
the T wave (13-17) . Examination of published tracings
showing arrhythmia onset (12) suggests that the dispersion of
ventricular repolarization is large . In keeping with this view
are the large differences between the durations of QT inter-
vals and the effective refractory period in the right and the
left ventricle (16) . Other evidence in support of marked
asynchrony of repolarization in these patients includes dif-
ferences in the durations of monophasic action potential in
different portions of the ventricles (18,1 ), marked variabil-
ity of the effective refractory period found during the explo-
ration of the right ventricle (20,21) and regional electrical
disparities in the ventricular recovery process established by
mapping of body surface potentials (22) .
Poisoning with organophosphorus compounds . These com-
pounds inhibit cholinesterase and produce intense vagal
stimulation . The mechanism of QT lengthening in this con-
dition is poorly understood, but both the ECG patterns and
the arrhythmias . that is, torsade de pointes, are similar to
those in patients with congenital long QT syndrome (23,24) .
Cerebrovascular accidents . Marked QTc lengthening oc-
curs in about 30% of patients with subarachnoid hemorrhage
and occasionally in patients with other types of cerebrovas-
cular accident (12) . However, the acquired neurogenic QTc
lengthening in these conditions is not a frequent cause of
torsade de pointes . probably because this QTc lengthening is
a transient phenomenon that is usually reversible within
days or weeks . Kuo et al. (25) found no increased incidence
of arrhythmia in 28 patients with a long QTc interval (0 .53 ±
0 .06 s), predominantly due to central nervous system disor-
ders in this group . However, Sen et al. (26) recorded torsade
de pointes in 2 of 72 patients with intracranial hemorrhage ; in
both. the QT interval was >550 ms . In another study (27),
torsade de pointes occurred in 5 (3 .8%) of 132 patients with
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subarachnoid hemorrhage ; in each of these 5 patients the QT
interval was >550 ms and hypokalemia was present .
Antiarrhythmic drugs . Although review of published
data suggests that torsade de pointes occurs during treat-
ment with those antiarrhythmic drugs that prolong the QT
interval, no relation between the arrhythmia and some
critical QTc value or some critical increase in QTc interval
has been established. Similarly, the occurrence of torsade de
pointes does not correlate with either the dose or the blood
concentration of any antiarrhythmic drug .
Quinidine . The largest number of cases of torsade de
pointer has been reported in patients treated with quinidine
(28-33), which is the oldest antiarrhythmic agent in the
category of sodium channel blocking drugs . In the quinidine-
treated patients, the incidence rate of torsade is about
1 .5%/year (34) . The arrhythmia tends to occur within I week
of initiation of treatment (35), and in one study of 31 patients,
approximately two-thirds had a prolonged QT interval while
not taking quinidine (36) . Other aggravating factors include
the presence of structural heart disease, hypokalemia (34,35)
and abrupt slowing of heart rate (34) . No correlation has
been established between the plasma concentration of quin-
idine, or dihydroquinidine, and the subsequent development
of torsade (37) .
Procainamide . Torsade de pointes has been reported in
patients treated with both procainamide (2,31,38) and its
metabolite, nor-acetyl procainamide (NAPA) (3 ) . Of the
two compounds, NAPA causes greater lengthening of the
QT interval . It has been suggested that patients receiving
procainamide, who have higher NAPA concentrations, are
either fast acetylators or have impaired renal function, and
that such individuals are at higher risk of developing arrhyth-
mia (40) .
Disopyramide and amiodarone . In patients treated with
disopyramide, torsade de pointer tends to occur in the early
stages of treatment, but there is no correlation between its
occurrence and the dose of the drug (2,32,38,41-44) . In
patients receiving amiodarone, torsade has been reported
during various states of treatment, including the loading
phase (45-48) . Similar to quinidine, with amiodarone the
risk of arrhythmia appears to be increased by hypoka-
lemia (45,4 ,50) . Other drugs in class IA category reported
to have caused torsade include aprindine (51) and ajmaline
(52) .
Beta-adrenergic and calcitnn channel blockers . Torsade
de pointes also occurs during treatment with antiarrhythmic
drugs that have no effect on the QRS duration but pro-
long the QTc interval ; these include, for example, the
beta-adrenergic blocking drug sotalol (53-57), the calcium
channel blocker bepridil (58-60) and drugs combining
both effects such as prenylamine (61,62) . In the sotalol-
treated patients, torsade occurred during treatment with
both conventional (54,55) and higher than normal (53,56,57)
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doses of the drug, and hypokalemia increased the risk of
arrhythmia (55) .
Metabolic disturbances . Torsade de pointes associated
with marked QT prolongation has been reported in patients
with hypothyroidism (63,64), anorexia nervosa (65), during
treatment with "liquid protein" diets (66,67) and other fad
weight-reducing diets (68,6 ) and during therapeutic starva-
tion (70) .
Hypokalemia . In hypokalemia, the QT interval is not
prolonged when it can be measured, but when the repolar-
ization is markedly distorted and the T wave merges with the
U wave, the QT interval is no longer measurable . Although
no direct relation has been established between the ampli-
tude of the T + U wave and torsade de pointes, hypokalemia
is a well known risk factor for this arrhythmia either alone or
in association with other factors . The onset of torsade de
pointes in hypokalemia is frequently precipitated by a ven-
tricular premature complex interrupting the T wave or the
T + U wave .
Other conditions. Torsade de pointes has been reported
in a variety of conditions associated with QT lengthening, for
example, after intracoronary contrast injections (71) and in
the presence of marked bradycardia (72-76) . Marked disper-
sion of repolarization was documented in patients with
permanent bradycardia, attacks of ventricular tachycardia
and long QT interval (77) . Other conditions include the
period after resuscitation (12) and therapy with thioridazine
(78), maprotiline (7 ), amantadine (80), vincamine (81) and
ketanserin (82) .
Frequency of occurrence . In one of the largest series of
cases collected over a period of 11 years, Salle et al . (83)
found that of the 60 cases of torsade de pointes, 21 were
associated with severe bradycardia and 16 with potassium
depletion; 23 were caused by drugs .
Treatment . The most effective treatment of torsade de
pointes is an increase in heart rate by pacing (31,84-87) . This
increase results in shortening of the QT interval, although
frequently without shortening of the QTc interval (88) . Also,
torsade de pointes may cease when the heart rate increases
spontaneously, for example, at the onset of atrial fibrillation
(8 ) . It is tempting to speculate that in some cases sponta-
neous termination of torsade de pointes results from an
increase in heart rate precipitated by hypotension occurring
during arrhythmia .
In the absence of pacing facilities, isoproterenol has been
used to terminate the arrhythmia (31,32,87, 0)
. The pre-
sumed mechanism of isoproterenol action is an increase in
heart rate and a decrease in dispersion of repolarization ( 1) .
In quinidine-intoxicated dogs, isoproterenol shortened the
QT and QTc intervals and made it more difficult to induce
polymorphic ventricular tachycardia by pacing ( 0) . Magne-
sium salts have been used successfully to treat torsade de
pointes ( 2, 3) .
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Normal and Abnormal Dispersion
of Repolarization
Definition . Dispersion of repolarization is a measure of
nonhomogeneous recovery of excitability in a given mass of
cardiac tissue and is determined by differences in activation
times and in the durations of action potentials ( 4) . This
definition is valid only if the excitability is strictly propor-
tional to the duration of repolarization, a condition appar-
ently fulfilled in the normal ventricular myocardium . How-
ever, in the diseased, depolarized and pharmacologically
altered myocardium, the recovery of excitability may lag
behind the completion of repolarization . If the activation
time differences remain unchanged, the dispersion of repo-
larization will be greater at slow than at fast heart rates .
In humans, the dispersion of QT intervals in precordial
maps ranged in one study of 50 normal subjects (average QT
interval 384,1) from 34 to 88 ms ( 5) . In another study ( 6) .
dispersion averaged 8  ms in normal subjects and 155 ms in
14 patients with prolonged QT (average QT 482 ms) .
Dispersion of monophasic action potentials . Monophasic
action potentials recorded with suction electrodes have the
same shape and duration as those of transmembrane action
potentials ( 7) . Simultaneous recording of monophasic ac-
tion potentials permits direct measurement of the contribu-
tion of the activation time differences and action potential
differences to the dispersion of repolarization of a propa-
gated impulse . The dispersion of monophasic action poten-
tial durations at different endocardial sites of the right
ventricle was up to 40 ms in normal subjects and from 100 to
270 ms in 10 patients with a long QT interval and a history of
torsade de pointes (1 ) . In another study ( 8) of human
subjects who had normal ECGs, the dispersion of monopha-
sic action potential durations averaged 41 .4 ms (range 21 to
64) at the left ventricular endocardial sites and 5  .3 ms
(range 45 to 73) at the left ventricular epicardial sites .
Role of Dispersion of Ventricular
Repolarization in Ventricular Arrhythmias
Other Than Torsade de Pointes
In studies of dogs, Han and Moe and their co-workers
( 1,  ) firmly established an association between nonuni-
form recovery of excitability and lowered ventricular fibril-
lation threshold . The mechanism by which the increases in
dispersion facilitate the induction of ventricular fibrillation is
difficult to unravel because the electric stimulation employed
in the measurements of ventricular fibrillation threshold
induces a number of complex changes in electrophysiologic
properties of cardiac fibers . including altered polarization .
automaticity and refractoriness (100) .
Propagation of premature impulse from an area with
shortened monophasic action potential . In the study of Kuo
et al. ( 4) dispersion was induced by a combination of
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general hypothermia and selective coronary artery perfusion
with warm blood . This induction increased the maximal
dispersion during atrial pacing nearly 10-fold, that is, to
III ± 16 ms, of which about 80% was due to increased
difference in monophasic action potential durations . Ventric-
ular arrhythmia did not occur spontaneously . However, in
each dog, when maximal dispersion reached a certain critical
value, an early premature ventricular stimulus applied at the
site in which monophasic action potential was shortened
induced repetitive ventricular responses progressing to ven-
tricular fibrillation . In each dog, ventricular fibrillation was
induced during pacing at a slower rate but not during pacing
at a faster rate (Fig . 2) . In each dog, ventricular fibrillation
was induced during stimulation at the site at which the
monophasic action potential duration was short, but no
arrhythmia could be induced in the presence of the same
dispersion during stimulation at the site at which the
monophasic action potential duration was long ( 4). This
study showed that the propagation of a premature impulse
from the site with short duration of monophasic action
potential to the sites with long duration of monophasic action
potential was slower than the propagation from the site with
long duration of monophasic action potential to the sites of
short monophasic action potential duration .
Kuo et al . ( 4) assumed that when the increase in disper-
sion of repolarization reached a critical level, propagation of
premature impulses originating from the area with a short
monophasic action potential encountered a block in the area
with a long monophasic action potential and created condi-
tions favorable for reentry. They concluded that the large
dispersion of repolarization is arrhythmogenic because it
creates an environment that facilitates the development of a
conduction delay required to induce a sustained arrhythmia .
The study suggested that the large monophasic action poten-
tial duration difference in their model played a crucial role
only in the process of initiation but not in the process of
maintenance of arrhythmia .
Reentry caused by slow conduction in incompletely repo-
larized myocardium . In another animal model in which large
increase of dispersion of regional QT intervals was induced
by intracoronary injections of Renografin 76, ventricular
fibrillation occurred both spontaneously and after premature
stimulation at the site of normal regional QT, that is, in the
non-Renografin perfused area (101) . The origin of the spon-
taneous premature complex initiating the arrhythmia was not
established, but the arrhythmia was attributed to reentry
caused by slow conduction in incompletely repolarized
myocardium (101) . In this animal model, administration of
calcium, which attenuated the local QT lengthening, pre-
vented the induction of ventricular fibrillation . This finding is
of some interest because the increase in calcium concentra-
tion may be expected to enhance afterdepolarizations that
have been postulated to precipitate arrhythmia in dogs with
prolonged action potential duration (see later) .
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Early Afterdepolarizations
In contradistinction to the late afterdepolarizations occur-
ring during diastole, the early afterdepolarizations occur
before repolarization is completed (102) . Early afterpoten-
tials may initiate depolarizations on reaching threshold po-
tential for either rapid or slow inward current . The mecha-
nism of afterdepolarizations is intimately related to that of
depolarization-induced automaticity resulting from decrease
in potassium conductance (103) . From his study of embry-
onic heart cells, Sperelakis (104) concluded that "all non-
pacemaker myocardial cells in culture are capable of being
converted into pacemaker cells by a decrease in potassium
conductance, and all pacemaker cells can be converted into
nonpacemaker cells by increasing potassium conductance ."
Some of the experimental procedures used to change the
myocardial nonpacemaker fibers into pacemaker fibers in-
clude   1) a decrease in extracellular potassium concentration
alone or together with a decrease in calcium concentration,
2) application of barium and cesium salts, 3) application of
aconitine, 4) stretch, and 5) application of electric currents .
Studies In Vitro
Low potassium . In 1 61, Antoni (105) induced automatic
activity in guinea pig atrial strips by lowering potassium with
the addition of acetylcholine and then driving the prepara-
tion at rapid rate. In 1 62, Gettes et al . (106) published
records of ventricular action potentials from isolated rabbit
hearts perfused with low potassium solution in the presence
and absence of quinidine (Fig. 3 and 4) . These records show
a smooth continuum from the diastolic depolarization
toward the upstroke of the subsequent ventricular action
potential .
In 1 65, Muller (107) elicited spontaneous automatic
activity in calf and sheep ventricular trabeculae superfused
with solution free of potassium and calcium . He explained
this phenomenon by a decrease in potassium conductance
due to low potassium and an increase in sodium conductance
due to calcium deficiency . Also, Carmeliet (108) used low
potassium perfusion to transform nonpacemaker fibers of
guinea pig left atria] myocardium into pacemaker fibers . He
first depolarized these fibers to <_-40 mV by application of
Figure 3 . Ventricular action potentials
and electrocardiogram from isolated rab-
bit heart perfused with low potassium
and 12 mg/liter quinidine solution . Note
the prolongation of action potential and
depolarizations arising from low mem-
brane potential . Reproduced from Ref .
106 with permission .
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Figure 2 . Effects of atrial pacing rate on
the maximal dispersion and the induction
of ventricular arrhythmia in an open chest
anesthetized dog during hypothermia com-
bined with regional warm blood perfusion .
From top to bottom, six monophasic ac-
tion potentials were recorded with suction
electrodes from the ventricular surface .
Numbers within each monophasic action
potential represent their duration in ms .
The dispersion defines the maximal differ-
ence between the ends of six simulta-
neously recorded monophasic action po-
tentials . The cycle length during atrial
pacing is 450 ms in A and 555 ms in B .
Ventricular arrhythmia was induced only
at a slower pacing rate when dispersion
was greater. The arrows labeled S show
the site of stimulation . Reproduced from
Ref.  4 with permission .
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Figure 4 . Ventricular action potentials
and electrocardiogram from isolated
rabbit heart before (A) and during (B to
D) low potassium perfusion . Note the
prolonged repolarization and smooth
transition from repolarization to depo-
larization in the first two premature
complexes in the bottom row . Other
premature complexes start abruptly
and are probably caused by depolariza-
tion transmitted from another fiber .
Reproduced from Ref . 106 with per-
mission .
potassium-free solution for 4 h and then reintroduced Ty-
rode's solution containing 2 .7 mM potassium. When the
membrane potential increased to about -60 mV, pacemaker
activity appeared and persisted for hours if the potassium
concentration was kept sufficiently low (108) .
In discussing possible mechanisms, all investigators pos-
tulated that low potassium decreases potassium conductance
and causes depolarization that permits sustained automatic
activity in the presence of a sufficient background inward
current. Judging from the reported levels of depolarization,
the inward current is probably supplied by the incompletely
inactivated rapid inward sodium current .
Blockers of potassium conductance . blockers of potas-
sium conductance representing predominantly the blockers
of the time-independent inward rectifier (iK,) (10 ), for
example, barium, cesium and 4-aminopyridine, are capable
of transforming nonpacemaker fibers into pacemaker fibers .
Aconitine . Topical application of aconitine to myocar-
dium is known to produce rapid ectopic depolarizations .
Heistracher and Pillat (110) showed that 10 -7 g/liter aconi-
tine in tissue bath caused slow diastolic depolarization and
pacemaker activity in cat papillary muscle .
Stretch . Kaufmann and Theophile (I 11) found that
stretch transformed normal atrial and ventricular monkey
muscle fibers into pacemaker fibers . The critical stretch
force was about 3 .8 g . and the extension of the stretched
preparation averaged 141 -± 15% of the rest length of the
unloaded preparation . Less stretch was needed to induce
automaticity in Purkinje fibers and in thin rather than in thick
muscle bundles . The process was reversible .
Application of electrical currents . Many studies (112,113)
have shown that depolarization induced by application of
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currents in tissue bath induces automatic activity in non-
pacemaker fibers in atrial and ventricular tissues of various
species . In some of these preparations, the threshold poten-
tial for the induction of automatic activity was at the levels
more negative than -60 mV, that is, the levels at which the
rapid sodium inward current could be responsible for the
maintenance of depolarizations . However, in the majority of
studies, the threshold potential for automatic depolarizations
was less negative, and the depolarizations were dependent
on slow inward current . This type of automaticity was
suppressed by verapamil and increased potassium concen-
tration but not appreciably affected by the sodium channel
blocker lidocaine (114) (Fig . 5) .
Early afterdepolarizations in Purkinje fibers . The de-
crease in potassium conductance facilitates the occurrence
of early afterdepolarizations in the Purkinje fibers in the
same manner as in the ventricular nonpacemaker fibers .
Early afterdepolarizations occurring in Purkinje fibers may
be transmitted electrotonically to the ventricular muscle
fibers and distort the course of their repolarization . In
quiescent canine Purkinje fibers, early afterdepolarizations
have been elicited by superfusion with quinidine at low
potassium concentration and at long cycles (115), hypoxic
acid Tyrode's solution, with or without epinephrine, or
nickel (116), and in fibers loaded with tetraethylammonium
chloride (117) (Fig . 6) .
Studies In Vivo
Cesium administrations . In anesthetized dogs, cesium
chloride administration intravenously prolonged the QT in-
terval (118) and the monophasic action potentials recorded
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Figure 5 . Effect of lidocaine (8 mg/liter) on ventricular action
potential of guinea pig (column 1) and rhythmic automatic depolar-
izations induced by depolarization to about -40 mV (column 2) . A,
Control . B, 30 min after onset of superfusion with lidocaine . C, 40
min after return to control Tyrode's solution . Each panel in column
2 shows the trace of depolarizing current at the top and the
membrane potential at the bottom . Note that lidocaine shortens the
duration of ventricular action potential, decreases the overshoot and
the Vm , X (inverted trace at the top) but has minimal effect on the rate
and amplitude of rhythmic automatic depolarizations . Reproduced
from Ref. 114 with permission .
with suction electrodes (11 ) . Cesium also induced afterde-
polarizations and ventricular arrhythmias in anesthetized
dogs. There was a good correlation between the durations of
QT and monophasic action potential and between the timing
of afterdepolarization and the coupling interval of ventricu-
lar ectopic complexes. In some cesium-treated animals,
afterdepolarizations were induced by norepinephrine and
suppressed by propranolol (11 ) .
Long QT syndromes . In patients with congenital long QT
syndrome, slow diastolic waves and humps resembling af-
terdepolarizations have been recorded in the electrograms
from various endocardial sites in both ventricles (120) and in
the tracings of right ventricular endocardial monophasic
action potentials (1 ) (Fig . 7) . Similar "afterdepolarizations"
have been recorded in association with prolonged monopha-
sic action potential caused by hypokalemia . hypocalcemia .
AV block and antiarrhythmic drugs (1 ) .
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Relative Strengths of the Two Hypotheses  
Increased Dispersion of Repolarization
Versus Afterdepolarizations
Genesis of afterdepolarizations . Clinical observations (12)
established the presence of increased dispersion of ventric-
ular refractory periods and monophasic action potential
durations in several patients with the long QT syndrome .
Similarly, there are observations compatible with the pres-
ence of afterdepolarizations (1 ,120) . The difference be-
tween these two sets of observations is that the effective
refractory periods and monophasic action potential dura-
tions can be measured reliably with little error, whereas
there is no assurance that an afterpotential recorded with
extracellular electrodes is not a motion artifact ( 7) or a
result of an electrotonic interaction with neighboring cells
(121) . Figures 8 and   show that "afterdepolarizations"
recorded in the tracings of monophasic action potentials may
occur in the absence of similar deflections in the records of
transmembrane action potentials, and that the "afterdepo-
larizations" increase in amplitude with increasing force of
contraction and disappear when contraction weakens . These
observations suggest that afterdepolarizations may represent
motion artifacts and cause concern about the genesis of
similar deflections illustrated in many of the published rec-
ords of afterdepolarizations (Fig . 7) . However, even if the
existence of early afterpotentials after action potentials of
long duration was established, their possible role in the
arrhythmia genesis would need to be documented . The
same, of course, applies to the increased dispersion of
repolarization .
Conditions producing increased dispersion of repolariza-
tion . The existing models of arrhythmias dependent on
increased dispersion in the experimental animals in vivo
produce conditions that would seldom be encountered in
clinical practice, large temperature gradients ( 4) or injec-
tions of massive doses of contrast into coronary artery (101) .
Similarly, the experimental models of afterdepolarization-
intravenous administration of cesium chloride solutions, for
example (I 1 ,120)-do not resemble conditions encountered
in practice . Unfortunately, the question of the mechanism of
the torsade de pointes associated with long QT interval is not
answered by clinical observations because most of these
observations can be explained by both mechanisms . How-
ever, the ensuing discussion will show that in some instances
difficulties are encountered for the afterpotential hypothesis .
Hypothesis to Explain Characteristics of'
Ventricular Arrhythmias Associated With Long
QT Interval
An acceptable hypothesis must explain the following
characteristics of ventricular tachyarrhythmias associated
with long QT interval .
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Figure 6 . Effect of intracellular loading with tetra-
ethylammonium chloride in cardiac canine Purkinje
fiber at low (0 .54 mM) and high (10 .8 mM) (K+)„ in
Tyrode's solution . A, Continuous recording during
change from control Tyrode's solution ([K+]„ = 5 .4
mMl to low potassium solution . Note the lengthen-
ing of action potential and hyperpolarization (a ver-
sus b), B, Change from low potassium to high
potassium solution at the time of the beginning of the
record . Note the automatic activity, arrest at a low
membrane potential, slow repolarization, followed
by abrupt repolarization at a potential of about -60
mV (arrow) . Also note the early afterdepolarizations
arising from a low level of membrane potential
during the plateau of the action potentials and before
the arrest . Reproduced from unpublished experi-
ments of S . Ito and B . Surawicz .
1) Facilitation by slow heart rate and occurrence after a
long preceding RR interval . Dispersion of repolarization is
expected to increase with increasing cycle length . However,
a slow heart rate also facilitates the occurrence of afterde-
polarizations (122) .
2) Suppression by rapid pacing . This procedure will be
expected to decrease the dispersion of repolarization ( 4)
and also suppress the propensity to development of early
afterdepolarizations (123) .
3) R on T phenomenon . In the presence of a long QT
interval or prolonged terminal repolarization resulting in
fusion of T wave and U wave, the torsade de pointer is
frequently precipitated by a premature complex interrupting
the T wave . Although this phenomenon is a marker of
increased dispersion of ventricular repolarization (l2), it
does not rule out the possible role of early afterdepolariza-
tion in the genesis of premature depolarization .
4) Difficulty of arrhythmia induction with programmed
electrical stimulation . Such difficulty may be due to several
factors   a) critical dispersion of repolarization is not present
during the study ; b) pacing before introduction of premature
stimuli decreases the dispersion of repolarization ; or c)
premature stimuli are not effective because they are not
being applied at the site of the short refractory period . In the
Figure 7. An example of possible af-
terdepolarizations in the monophasic
action potentials (MAP) recorded with
suction electrodes . Surface electrocar-
diogram and monophasic action poten-
tials from two different regions of the
right ventricle (RV) in an 82 year old
woman with long QT caused by 2  1
atrioventricular block . Arrows point at
humps of varying amplitude and dura-
tion . These humps are attributed by
Bonatti et al . (1 ) to abnormalities of
repolarization rather than to motion
artifacts . Reproduced from Ref. 1 
with permission .
a -L
Abnormal
RV MAP
	 1%
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experimental model of arrhythmias dependent on critical
dispersion ( 4), arrhythmia could be induced only from the
sites at which the monophasic action potential duration was
short. The same may be expected in patients with a long QT
interval . Therefore, the inappropriate site of stimulation may
explain the difficulty of inducing reentry in the presence of
increased dispersion of repolarization. However, it is con-
ceivable that the induction of early afterdepolarizations may
also depend on the site of stimulation .
5) Aggravation of arrhythmia by hypokalemia . Lengthen-
ing of the terminal portion of repolarization by hypokalemia
is expected to prolong the relative refractory period and
increase dispersion of repolarization. However, low potas-
sium concentrations and the depolarizing effect of hypokale-
mia may also facilitate the appearance of early afterdepolar-
izations .
6) Lack of strict correlation between the doses or plasma
concentrations of drugs eliciting torsade de pointes and the
occurrence of arrhythmia . Treatment with various doses of
quinidine, procainamide and other class 1A antiarrhythmic
drugs provokes arrhythmias in only a small minority of
patients . It is plausible that in the majority of treated patients
proarrhythmic effects do not occur because the lengthening
of repolarization induced by these drugs does not result in
P
a
P
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Figure 8 . Simultaneously recorded tracings of action potential from
isolated perfused rabbit heart registered with the intracellular mi-
croelectrode (upper row) and suction electrode (lower row, reversed
polarity) . At the arrow, the amplitude of the monophasic action
potential suddenly decreases and afterpotentials appear. whereas
the transmembrane potential shows no change . Reproduced from
Ref.  7 with permission .
increased dispersion of repolarization . In dogs, quinidine
prolonged the effective refractory period and monophasic
action potential duration but did not increase dispersion of
repolarization measured at several right ventricular sites
(124) . In humans, procainamide prolonged the QT interval
and effective refractory period but did not alter dispersion
measured at three right ventricular sites (125) . In the small
subset of susceptible patients treated with antiarrhythmic
drugs causing QTc lengthening, ventricular tachyarrhyth-
mias tend to occur within the first few days of treatment
when plasma drug concentrations are within the therapeutic
range. In such cases, arrhythmias are attributed to an
idiosyncratic reaction, perhaps signifying latent long QT
syndrome and increased dispersion of repolarization . How-
ever, afterdepolarizations have been recorded in Purkinje
fibers at low quinidine and low potassium concentrations
(115) . Whether such afterdepolarizations occur in vivo in the
Purkinje or ventricular muscle fibers at low drug concentra-
tions in the presence or the absence of hypokalemia is not
known .
7) Spontaneous termination . The propensity to terminate
spontaneously makes torsade de pointes more similar to
ventricular tachycardia than to ventricular fibrillation . It
appears that polymorphic ventricular tachycardias terminate
spontaneously more often than do monomorphic tachycar-
dias. In an arrhythmia dependent on dispersion of repolar-
ization, spontaneous termination probably represents block
in the pathway of reentry . In an arrhythmia dependent on
afterdepolarization, spontaneous termination may be due to
hyperpolarization precipitated by a local increase in potas-
sium concentration or other factors . In vitro, afterdepolar-
izations arising from a low membrane potential in Purkinje
fibers often terminate spontaneously (115,116) .
8) Effect of magnesium . Intravenous administration of
magnesium salts terminated torsade de pointes associated
with QT prolongation (and hypokalemia in most patients) but
had no effect on the polymorphic ventricular tachycardia in
patients with normal QT intervals ( 3) . Consistent with
earlier observations (126,127) . magnesium did not shorten
the prolonged QT interval ( 3) . Magnesium also suppressed
ventricular arrhythmias and attenuated early afterdepolar-
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Figure   . Examples of apparent afterdepolar-
izations appearing in the records of monopha-
sic action potentials (MAP) recorded with
suction electrodes from the surface of per-
fused rabbit hearts, simultaneously with the
electrocardiogram (ECG) (A, B, D), intraven-
tricular pressure (Pr) (B) and transmembrane
action potential recorded with intracellular
microelectrode (upper trace in C and D) . A,
The amplitude of afterdepolarizations in-
creases progressively when calcium concen-
tration is tripled (control 2 .7 mM)  the straight
line below connects the points of onset of
afterdepolarizations . B, Afterdepolarization
disappears when calcium concentration is 10
times lower than that of control   note disap-
pearance of intraventricular pressure (Pr) at
low calcium and increased duration of QT
expressed as percent of RR interval . C and D,
Afterdepolarizations in monophasic action
potential (lower and middle trace, respectively)
occur in the absence of corresponding deflec-
tions in transmembrane action potential
(upper trace) . Reproduced in part from Ref .
 7 with permission and in part from unpub-
lished observations of E . Lepeschkin, H .
Herrlich and B . Surawicz .
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izations in cesium-treated dogs (128) . Although the latter
experiments add support to the afterdepolarization theory of
torsade de pointes, it must be remembered that magnesium
has been effective in treatment of various other arrhythmias
(12 -132), in particular those associated with digitalis toxic-
ity (130) . Magnesium may suppress arrhythmia because it is
a weak blocker of the calcium channel (133) . Also, magne-
sium shifts the steady state inactivation curve of the fast
sodium channel in the depolarizing direction . and thereby
increases the maximal velocity of the action potential (Vm,, X )
in depolarized ventricular fibers (134) . This effect could
explain the suppression of arrhythmia in the presence of low
potassium conductance or digitalis toxicity .
 ) Effect of isoproterenol . The assumed mechanism of
action is decreased dispersion of repolarization due to in-
crease in rate and shortening of action potential duration .
The therapeutic effect of isoproterenol is difficult to recon-
cile with the hypothesis of early afterdepolarizations, be-
cause isoproterenol is expected to facilitate rather than
suppress their occurrence .
10) Induction of torsade de pointes by sotalol . This anti-
arrhythmic drug is a beta-adrenergic blocker that prolongs
the duration of action potential . The induction of torsade de
pointes by sotalol is more likely related to increased disper-
sion of repolarization than to early afterdepolarizations
because beta-adrenergic blockade is known to suppress
early afterdepolarizations (135) .
11) Induction of torsade de pointes by bepridil and prenyl-
amine (calcium channel blockers that prolong action potential
duration) . The induction of torsade de pointes by bepridil
and prenylamine is more likely related to increased disper-
sion of repolarization because calcium channel blockers are
known to suppress early afterdepolarizations (136) .
Conclusions
Which of the two electrophysiologic substrates is respon-
sible for torsade de pointes in the presence of a long QT
interval or increased U wave amplitude? It may be that each
of these substrates exists under appropriate circumstances .
For instance, in patients with hypokalemia alone or in
association with sodium channel blocking antiarrhythmic
drugs, slowing of repolarization may result in the occurrence
of spontaneous depolarization before repolarization is com-
pleted (106) . However, under other circumstances when
prolonged repolarization is associated with a stable diastolic
potential, the arrhythmia is probably caused by reentry
facilitated by increased dispersion of repolarization . At this
time neither of the two proposed substrates has been con-
clusively documented as the cause of torsade de pointes in
humans. The elucidation of the mechanisms of ventricular
arrhythmias associated with long QT interval requires fur-
ther investigation .
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